Association of IRF5 Polymorphisms with systemic lupus erythematosus in a Japanese population

被引:85
作者
Kawasaki, Aya [1 ]
Kyogoku, Chieko [2 ]
Ohashi, Jun [3 ]
Miyashita, Risa [3 ]
Hikami, Koki [1 ]
Kusaoi, Makio [4 ]
Tokunaga, Katsushi [3 ]
Takasaki, Yoshinari [4 ]
Hashimoto, Hiroshi [4 ]
Behrens, Timothy W. [2 ]
Tsuchiya, Naoyuki [1 ]
机构
[1] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Social & Environm Med, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Minnesota, Minneapolis, MN USA
[3] Univ Tokyo, Tokyo, Japan
[4] Juntendo Univ, Tokyo, Japan
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 03期
关键词
D O I
10.1002/art.23216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine whether the IRF5 gene, which encodes interferon regulatory factor 5, is associated with systemic lupus erythematosus (SLE) in a Japanese population. Methods. A case-control study was performed in 277 SLE patients and 201 healthy controls. Associations between the IRF5 genotype and levels of messenger RNA (mRNA) for interferon (IFN) pathway genes were examined using an mRNA expression database of HapMap samples. Results. Carriers of the rs2004640T single-nucleotide polymorphism, (SNP) were slightly increased among SLE patients (58.8%) as compared with controls (50.2%). When data from our Japanese population were combined with previously published data from a Korean population, the T allele frequency was found to be significantly increased in SLE patients (P = 8.3 x 10(-5)). While no association was observed for the rs10954213 SNP or the exon 6 insertion/deletion, significant associations with 3 intron 1 SNPs (-4001, rs6953165, and rs41298401) were found. The allele frequency of rs41298401G was significantly decreased in SLE patients (13.0% versus 18.7% in controls; P = 0.017), and the allele frequency of rs6953165G, which was in absolute linkage disequilibrium with -4001A, was increased in SLE patients (8.8% versus 5.2% in controls; P = 0.034). The Caucasian risk haplotype was not present; instead, a protective haplotype carrying rs2004640G, rs41298401G, the deletion in exon 6, and rs10954213A was identified. SNP rs10954213, but not intron I SNPs, was associated with IRF5 at the mRNA level; nevertheless, intron 1 SNPs were also associated with levels of mRNA for several IFN pathway genes, suggesting a functional role. Conclusion. IRF5 was found to be associated with SLE in Asian populations. Intron 1 SNPs, rather than exon 6 and 3'-untranslated region polymorphisms, appeared to play a crucial role.
引用
收藏
页码:826 / 834
页数:9
相关论文
共 24 条
[1]   Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].
Baechler, EC ;
Batliwalla, FM ;
Karypis, G ;
Gaffney, PM ;
Ortmann, WA ;
Espe, KJ ;
Shark, KB ;
Grande, WJ ;
Hughes, KM ;
Kapur, V ;
Gregersen, PK ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615
[2]   Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection [J].
Barnes, BJ ;
Richards, J ;
Mancl, M ;
Hanash, S ;
Beretta, L ;
Pitha, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :45194-45207
[3]   Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes [J].
Barnes, BJ ;
Kellum, MJ ;
Field, AE ;
Pitha, PM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (16) :5721-5740
[4]   Interferon and granulopoiesis signatures in systemic lupus erythematosus blood [J].
Bennett, L ;
Palucka, AK ;
Arce, E ;
Cantrell, V ;
Borvak, J ;
Banchereau, J ;
Pascual, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :711-723
[5]   Interferon-α:: A new target for therapy in systemic lupus erythematosus? [J].
Crow, MK .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2396-2401
[6]   Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE) [J].
Demirci, F. Y. K. ;
Manzi, S. ;
Ramsey-Goldman, R. ;
Minster, R. L. ;
Kenney, M. ;
Shaw, P. S. ;
Dunlop-Thomas, C. M. ;
Kao, A. H. ;
Rhew, E. ;
Bontempo, F. ;
Kammerer, C. ;
Kamboh, M. I. .
ANNALS OF HUMAN GENETICS, 2007, 71 :308-311
[7]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[8]   Opposed independent effects and epistasis in the complex association of IRF5 to SLE [J].
Ferreiro-Neira, I. ;
Calaza, M. ;
Alonso-Perez, E. ;
Marchini, M. ;
Scorza, R. ;
Sebastiani, G. D. ;
Blanco, F. J. ;
Rego, I. ;
Pullmann, R., Jr. ;
Pullmann, R. ;
Kallenberg, C. G. ;
Bijl, M. ;
Skopouli, F. N. ;
Mavromati, M. ;
Migliaresi, S. ;
Barizzone, N. ;
Ruzickova, S. ;
Dostal, C. ;
Schmidt, R. E. ;
Witte, T. ;
Papasteriades, C. ;
Kappou-Rigatou, I. ;
Endreffy, E. ;
Kovacs, A. ;
Ordi-Ros, J. ;
Balada, E. ;
Carreira, P. ;
Gomez-Reino, J. J. ;
Gonzalez, A. .
GENES AND IMMUNITY, 2007, 8 (05) :429-438
[9]   Association of IRF5 in UKSLE families identifies a variant involved in polyadenylation [J].
Graham, Deborah S. Cunninghame ;
Manku, Harinder ;
Wagner, Susanne ;
Reid, Julia ;
Timms, Kirsten ;
Gutin, Alexander ;
Lanchbury, Jerry S. ;
Vyse, Tim J. .
HUMAN MOLECULAR GENETICS, 2007, 16 (06) :579-591
[10]   Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus [J].
Graham, Robert R. ;
Kyogoku, Chieko ;
Sigurdsson, Snaevar ;
Vlasova, Irina A. ;
Davies, Leela R. L. ;
Baechler, Emily C. ;
Plenge, Robert M. ;
Koeuth, Thearith ;
Ortmann, Ward A. ;
Hom, Geoffrey ;
Bauer, Jason W. ;
Gillett, Clarence ;
Burtt, Noel ;
Graham, Deborah S. Cunninghame ;
Onofrio, Robert ;
Petri, Michelle ;
Gunnarsson, Iva ;
Svenungsson, Elisabet ;
Ronnblom, Lars ;
Nordmark, Gunnel ;
Gregersen, Peter K. ;
Moser, Kathy ;
Gaffney, Patrick M. ;
Criswell, Lindsey A. ;
Vyse, Timothy J. ;
Syvanen, Ann-Christine ;
Bohjanen, Paul R. ;
Daly, Mark J. ;
Behrens, Timothy W. ;
Altshuler, David .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (16) :6758-6763